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Abstract
Purpose
To investigate the thickness of the retinal layers and to assess the prevalence of macular
microcysts (MM) in the inner nuclear layer (INL) of patients with mitochondrial optic neurop-
athies (MON).
Methods
All patients with molecularly confirmed MON, i.e. Leber’s Hereditary Optic Neuropathy
(LHON) and Dominant Optic Atrophy (DOA), referred between 2010 and 2012 were en-
rolled. Eight patients with MM were compared with two control groups: MON patients with-
out MMmatched by age, peripapillary retinal nerve fiber layer (RNFL) thickness, and visual
acuity, as well as age-matched controls. Retinal segmentation was performed using specific
Optical coherence tomography (OCT) software (Carl Zeiss Meditec). Macular segmentation
thickness values of the three groups were compared by one-way analysis of variance with
Bonferroni post hoc corrections.
Results
MMwere identified in 5/90 (5.6%) patients with LHON and 3/58 (5.2%) with DOA. The INL
was thicker in patients with MON compared to controls regardless of the presence of MM
[133.1±7μm vs 122.3±9μm in MM patients (p<0.01) and 128.5±8μm vs. 122.3±9μm in no-
MM patients (p<0.05)], however the outer nuclear layer (ONL) was thicker in patients with
MM (101.4±1mμ) compared to patients without MM [77.5±8mμ (p<0.001)] and controls
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[78.4±7mμ (p<0.001)]. ONL thickness did not significantly differ between patients without
MM and controls.
Conclusion
The prevalence of MM in MON is low (5-6%), but associated with ONL thickening. We spec-
ulate that in MON patients with MM, vitreo-retinal traction contributes to the thickening of
ONL as well as to the production of cystic spaces.
Introduction
Mitochondrial optic neuropathies (MON) are a group of hereditary diseases characterized by
variable degrees of optic nerve atrophy, caused by mitochondrial dysfunction and consequent
loss of retinal ganglion cells (RGCs) [1, 2]. The two most frequent non-syndromic forms of
MON are Leber’s hereditary optic neuropathy (LHON) and dominant optic atrophy (DOA).
LHON is a maternally inherited blinding disease due in 90–95% of cases to three primary mi-
tochondrial DNA point mutations (11778/ND4, 3460/ND1 and 14484/ND6), affecting the
mitochondrial respiratory complex I [3]. DOA is an autosomal dominant disorder due, in
the large majority of cases, to heterozygous mutations in the OPA1 gene [4, 5]. The clinical
expression of both LHON and DOA is characterized by the early and preferential involve-
ment of the papillomacular bundle that often expands to a widespread loss of axons in the
optic nerve, ultimately leading to severe optic atrophy [1, 2]. Consistent with this pattern of
fiber loss, LHON and DOA patients experience central vision loss with central scotoma
and dyschromatopsia, subacute for LHON and slowly progressive in DOA. These neurode-
generative disorders differ substantially in their pathogenic mechanism and clinical course
from inflammatory optic neuritis as seen in multiple sclerosis (MS) or neuromyelitis optica
(NMO) [6].
Optical coherence tomography (OCT) has become an essential tool for both diagnosis and
follow-up of LHON and DOA patients. Previous studies carried out by time-domain OCT
(TD-OCT) showed an increased thickness of the peripapillary retinal nerve fiber layer (RNFL)
in the temporal quadrant in LHON carriers [7], a thicker RNFL in all quadrants except the
temporal in patients with early LHON and a thinner RNFL in all quadrants in chronic LHON
and DOA patients [8, 9]. OCT has also been extensively used in studying inflammatory optic
neuritis, revealing that even in patients with MS without any episode of optic neuritis there is a
measurable and progressive loss of axons and reduction of RNFL thickness [10].
Recently, spectral-domain OCT (SD-OCT) has been utilized for further characterizing the
axonal loss and retinal features in both MON and inflammatory optic neuritis. In particular,
SD-OCT investigations led to the recent observation of macular microcysts (MM) in inflam-
matory optic neuritis in MS and NMO, possibly correlating with the severity of the disease pro-
cess [11–14]. It has been proposed that these changes may be useful in identifying the
inflammatory nature of the pathology [11, 13]. However, in addition to patients with MS and
NMO, MM have also been described in a case of compressive optic neuropathy [15], in optic
neuritis not due to MS [16, 17], and in glaucoma [18]. We first noticed MM in LHON and
DOA patients in 2009 (unpublished data) and recently discussed their nature, showing that
SD-OCT could identify them in the inner nuclear layer (INL) of the macula in a small sub-
group of MON patients in the absence of any leakage at the fluorescein angiography, thus add-
ing other conditions in which MMmay occur [19, 20].
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In the present study, we used SD-OCT with macular segmentation to 1) assess the preva-
lence of MM in patients with LHON and DOA, 2) investigate the thickness of the different reti-
nal layers in MON with and without MM, and 3) evaluate any difference between LHON and
DOA patients with MM.
Methods
Study design and participants
We prospectively enrolled all patients with molecularly confirmed diagnoses of LHON
(mtDNA pathogenic mutation) or DOA (OPA1 mutation) referred to the Unit of Neurology
of the University of Bologna between 2010 and 2012. Ninety LHON patients and 58 DOA pa-
tients had an extensive ophthalmologic examination, including best-corrected visual acuity
measurement, slit lamp biomicroscopy, intraocular pressure measurement, indirect ophthal-
moscopy, optic nerve head photography and SD-OCT. Exclusion criteria were the presence of
any retinal pathology and/or optic nerve disease other than LHON or DOA. We also excluded,
in order to avoid confounding factors such as RNFL swelling, LHON patients in the acute
phase (within two years from disease onset) or LHON patients with an atypically slowly pro-
gressive course.
Five LHON and three DOA patients with MM were identified (5.6% and 5.2% respectively).
Due to the small sample size of the cohort both eyes of the eight patients with MM (13 eyes)
were considered for the statitical analysis in comparison with the two control groups: 1) a sam-
ple of LHON and DOA patients without MMmatched by age, RNFL thickness, visual acuity
(36 patients), and 2) a control group (22 individuals). For the latter the inclusion criteria were
the following: best corrected visual acuity above 1.0 decimals, normal appearance of the optic
disc, normal visual field (the latter was examined with a SITA 24–2 standard test in all subjects
using the Humphrey VF analyzer, HFA II 750–4.1 2005, Carl Zeiss Meditec Inc, USA), absence
of significant ocular disease found by routine ophthalmological examination, absence of glau-
coma history in the family and/or absence of systemic diseases with possible ocular involve-
ment, such as diabetes mellitus. From this sample we randomly selected 22 eyes of 22 subjects
matching the hereditary MON patients group for age, since this factor has been shown to influ-
ence peripapillary RNFL thickness, as measured by SD-OCT [21, 22]. Age has also been shown
to influence the macular ganglion cell-inner plexiform layer (GCIPL) thickness [23]. In addi-
tion, inclusion criteria for both patients and controls were: refractive error between -3 and +3
diopters of sphere and between -2 and +2 diopters of cylinder, intraocular pressure less<21
mmHg and absence of any other disease of the retina and/or optic nerve.
All participants gave their written informed consent for clinical and genetic investigations
according to the Declaration of Helsinki and the study was approved by the internal review
board at the University of Bologna (protocol number 123/2006/U/Sper).
Procedures
All subjects underwent retinal nerve fiber layer (RNFL) thickness and ganglion cell layer-inner
plexiform layer (GC-IPL) thickness measurements by SD-OCT (Cirrus HD-OCT, software
version 6.0; Carl Zeiss Meditec, Inc, Dublin, CA, USA). All scans were acquired using the Optic
Disc Cube 200x200 and the Macular Cube 512x128 protocols. After the patient had been prop-
erly seated and aligned, the iris was brought into view using the mouse-driven alignment sys-
tem and the ophthalmoscopic image was focused. In order to acquire the Optic Disc Cube, the
ONH was centered on the live image before the centering and enhancement was optimized.
After the scanning process was launched, the instrument’s 840 nm wavelength laser beam gen-
erated a cube of data measuring 6 mm x 6 mm after scanning a series of 200 B-scans with 200
Macular Microcysts in MON
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A-scans per B-scan (40,000 points) in 1.5 seconds (27,000 A-scans/sec). Cirrus HD-OCT algo-
rithms found the optic disc and automatically placed a calculation circle of 3.46 mm diameter
evenly around it. Layer-seeking algorithms found the RNFL inner (anterior) boundary and
RNFL outer (posterior) boundary for the entire cube, excepting the optic disc. The system ex-
tracted from the data cube 256 A-scan samples along the path of the calculation circle. The re-
sulting temporal, superior, nasal, inferior, temporal profile map was equivalent to the Stratus
peripapillary RNFL (pRNFL) scan provided by TD-OCT (Stratus OCT, Carl Zeiss Meditec,
Dublin, CA).
The ONH parameters reported resulted from a fully automatic algorithm that defined both
the optic disc and cup margins within the three-dimensional data cube. The disc margin was
defined as the termination of Bruch’s membrane (also referred to as “neural canal opening” or
“Bruch’s membrane opening”) [24].
In order to acquire the Macular Cube, patients were asked to fixate on the central target.
Macular data were analyzed by means of the Ganglion Cell Analysis (GCA) algorithm, which
detected and measured the thickness of the macular ganglion cell-inner plexiform layer
(GC-IPL) within a 14.13-mm2 elliptical annulus area centered on the fovea (Fig 1). The size
and shape of the annulus were chosen because this conforms more closely to the real anatomy,
and this annulus corresponds to the area where the RGC layer is thickest in normal eyes.
The average, minimum, and six sectoral (superotemporal, superior, superonasal, inferonasal,
inferior, inferotemporal) GC-IPL thicknesses were measured from the elliptical annulus. A de-
tailed description of how the algorithm operates has been presented in detail [23]. Retinal seg-
mentation was carried out according to the technique described by Saidha et al. using specific
software provided by Carl Zeiss Meditec (Fig 2) [13]. Segmentation undertaken in three dimen-
sions identified the outer boundary of the macular RNFL (mRNFL), the outer boundary of the
inner plexiform layer (IPL), and the outer boundary of the outer plexiform layer (OPL) (Fig 2).
It could therefore yield the thicknesses of the following macular layers: the mRNFL, GCL and
inner plexiform layer (GCL-IPL, given by the difference between the mRNFL and the IPL seg-
mentation), inner nuclear layer (INL) including the outer plexiform layer (given by the differ-
ence between the IPL and OPL segmentations), and outer nuclear layer (ONL) including inner
and outer photoreceptor segments (given by the difference between the OPL and the retinal
pigment epithelium segmentation identified by regular Cirrus algorithm).
Only high-quality scans, defined as scans with signal strength 7, without RNFL disconti-
nuity or misalignment, involuntary saccadic or blinking artifacts, and absence of algorithm seg-
mentation failure on careful visual inspection, were used for analysis.
Statistical analysis
The measurements of the macular segmentation thickness were compared among the 3 groups
by one-way analysis of variance (ANOVA). For post-hoc pairwise comparisons between
groups Bonferroni correction was applied. The means, standard deviation (SD) of means, and
Pearson’s correlation coefficient were calculated. All statistical analyses were performed using
GraphPad InStat 3 for Macintosh and p value<0.05 was considered statistically significant.
Results
Prevalence of MM and demographic data of the investigated samples
We investigated 90 LHON and 58 DOA patients. 81 LHON patients carried one of the three
common mtDNA point mutations (11778/ND4, 3460/ND1 and 14484/ND6) and 9 carried
rare mtDNA mutations (3733/ND1, 14482/ND6, 3890/ND1 and 14495/ND6) [25, 26]. All
DOA patients had a molecularly confirmed OPA1 mutation.
Macular Microcysts in MON
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Macular microcysts were identified in 5 patients out of 90 with LHON (5.6%) and 3 patients
out of 58 with DOA (5.2%) (Fig 3). Amongst LHON patients, 2 patients carried the 11778/
ND4, 1 patient the 3460/ND1, 1 patient the 14484/ND6 and 1 patient the 14459/ND6 muta-
tion. For DOA patients with OPA1 mutation, 1 patient carried 2708_11 delTTAG in exon 27, 1
patient c.2196_2197 dup AGAC in exon 22, and 1 patient c.1409A>G in exon 14. One LHON
patient with MM was excluded from the study because of motion artifacts that did not allow
the correct macular segmentation.
The control group of MON without MM was composed by 16 LHON patients who carried
the 11778/ND4 (14 patients), 3460/ND1 (1 patient) and 3890/ND1 (1 patient) mtDNAmuta-
tions and 20 DOA patients, who carried an OPA1 mutation.
Table 1 shows the demographic data of LHON and DOA patients with and without MM,
and age-matched controls.
Fig 1. Superimposition of peripapillar RNFL quadrants andmacular GC-IPL sectors to OCT fundus image. The four RNFL quadrants (temporal,
superior, nasal, inferior) and the six GC-IPL sectoral (superotemporal, superior, superonasal, inferonasal, inferior, inferotemporal) thicknesses were
measured from circular scan around the disc and from the elliptical annulus centered on the fovea respectively.
doi:10.1371/journal.pone.0127906.g001
Macular Microcysts in MON
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Macular segmentation in MON patients with and without MM vs control
group
ANOVA showed a statistically significant difference for all the examined parameters in the
three groups (p<0.0001 for all variables except INL thickness with p = 0.0009).
We found that total macular thickness (p<0.05 and p<0.001 respectively), mRNFL (p<0.001
both groups) and GCL-IPL thickness (p<0.001 both groups) were significantly reduced in both
groups of MON patients compared with controls (Table 2). Total macular thickness and
GCL-IPL were significantly higher in MON patients with MM compared to those without MM
(p<0.001), whereas the mRNFL thickness was not significantly different between the two groups.
The INL was thicker in MON patients with and without MM compared to healthy controls
(p<0.01 and p<0.05 respectively) but there was no significant difference between patients with
MM and without MM, probably due to the small sample size. Also the analysis of each perifoveal
sector failed to reveal any difference in terms of INL thickness betweenMON patients with and
without MM. The ONL was thicker in MON patients with MM compared to both MON patients
without MM (p<0.001) and controls (p<0.001), whereas no significant differences were detected
in the ONL layers betweenMON patients without MM and healthy controls (small sample size).
Each patient with MM showed the typical pattern previously reported: six patients with the
perifoveal crescent-shape distribution of the MM and five patients with the perifoveal oval-
shape distribution more extensive in the nasal sector [17–20].
Comparison between LHON and DOA patients
Table 3 separately compares the INL and ONL of LHON and DOA patients with and without
MM to controls.
INL thickness was increased in LHON with MM and DOA patients with and without MM
compared to controls (p<0.05 for LHON; p<0.01 and p<0.05 for DOA with and without MM
respectively), whereas there was no significant difference between LHON patients without MM
and controls. The INL thickness did not differ between LHON and DOA patients.
Fig 2. Sample OCT segmentation. Segmentation, by regular Cirrus algorithm, identifies the outer boundary of the macular RNFL (mRNFL), the outer
boundary of the inner plexiform layer (IPL), and the outer boundary of the outer plexiform layer (OPL).
doi:10.1371/journal.pone.0127906.g002
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Fig 3. Patients OCT foveal scans.Horizontal OCT scans revealed macular microcysts (MM) of the inner
nuclear layer in the four LHON patients and three DOA patients.
doi:10.1371/journal.pone.0127906.g003
Macular Microcysts in MON
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ONL was significantly thicker in LHON and DOA patients with MM compared to both
MON patients without MM and controls (p<0.001 for all groups), whereas ONL thickness was
not significantly different between MON patients without MM and healthy controls.
Furthermore, ONL thickness did not differ between LHON and DOA patients with MM.
Discussion
The present study demonstrates that MM occur in about 5–6% of patients with MON. This
finding strikingly differs from a report by Wolff et al. [27] in which MM were detected in 30
cases (75%) of optic atrophy due to mitochondrial dysfunction, but it is in close agreement
with previous studies on DOA patients reporting that only a minor fraction (about 4%) of
DOA patients has MM [28]. Detailed OCT retinal segmentation of the LHON and DOA pa-
tients compared with a control population shows that the innermost retinal layers (mRNFL,
GCL-IPL) are thinner in the MON patients, whereas the INL appears thicker in the MON pa-
tients (with or without MM) and ONL is significantly thicker only in the MM subgroup of
MON patients. The most likely explanation for these results is that the RGC loss directly re-
flects on the RNFL and GCC, which become thinner. If the retina is held by firm vitreo-retinal
adhesion then the underlying retina must either expand or split to form empty cystic spaces
(MM).
Table 1. Demographic, clinical characteristics of the study participants.
LHON DOA Healthy Controls
MM No-MM MM No-MM No-MM
Number of participants (number of eyes) 4 (7) 16 (16) 3 (6) 20 (20) 22 (22)
Age, years 30±6 31±9 35±13 37±16 34±12
Visual acuity, decimals 0.07±0.03 0.12±0.10 0.28±0.22 0.39±0.24 1.25
360° pRNFL, mμ 60±6 60±7 67±17 66±4 93±10
Data are mean (SD). LHON = Leber hereditary optic neuropathy. DOA = Dominant optic atrophy. pRNFL = peripapillary retinal nerve fiber layer.
MM = macular microcysts.
doi:10.1371/journal.pone.0127906.t001
Table 2. Comparison of optical coherence tomography parameters (different macular thickness layers) between all patients with and without mac-
ular microcysts and healthy controls.
Macular Thickness
Average (mμ)
MM no-
MM
Healthy
Controls
MM vs
controls
MM vs
No-MM
No-MM vs
controls
Rate of change MM
Vs controls (%)
Rate of change no-MM
Vs controls (%)
Total thickness 305.1
±2
271.3
±1
319.3±1 <0.05 <0.001 <0.001 -4.4 -15
mRNFL 13±2 14.3
±4
34.6±3 <0.001 ns <0.001 -62.4 -58.6
GCL-IPL 57.4
±6
50.9
±4
83.9±6 <0.001 <0.001 <0.001 -31.5 -39.3
INL 133.1
±7
128.5
±8
122.3±9 <0.01 ns <0.05 8.8 5
ONL 101.4
±1
77.5
±8
78.4±7 <0.001 <0.001 ns 29.3 -1
Data are mean (SD). LHON = Leber hereditary optic neuropathy. DOA = Dominant optic atrophy. MM = macular microcysts. mRNFL = macular retinal
nerve fiber layer. GCL-IPL = ganglion cell and inner plexiform layers. INL = inner nuclear layer including outer plexiform layers. ONL = outer nuclear layer
including inner and outer photoreceptor segments.
doi:10.1371/journal.pone.0127906.t002
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The total macular thickness is significantly thinner in patients without MM compared with
both patients with MM and controls. Our finding that the nuclear retinal layers (INL and
ONL) of patients with MON exhibit an increase in thickness compared to controls is of partic-
ularly interest. We postulate that, in conjunction with a reduction of RNFL and GCL-IPL
thicknesses, the retina is probably subjected to a negative pressure that limits further thinning
and leads to an increased thickness of the INL, the occasional formation of MM and a greater
thickening of the ONL in a subgroup of patients.
The greater percentage of increase in the thickness of the ONL compared with the INL
(29% vs 8.8% in patients with MM) and the lack of cyst formation in this layer might represent
a different elastic coefficient reflecting the different cell populations and architecture of these
layers. It is well-known that the compressive modulus of the choroid and RPE combined (a
loose vascular connective tissue and neuro-epithelial monolayer) is more than 40% lower than
that of the retina as a whole and this may affect the elastic response of the outer retinal layers
connected with RPE and subjected to vitreous adhesion or traction [29].
The force with the above-mentioned characteristics, which might be a factor for these
changes, is posterior vitreo-macular traction (VMT) due to persistent vitreo-macular adhesion
and likely vitreo-papillary adhesion. All eyes with MM, in fact, showed persistent adherence of
posterior vitreous cortex to the macula. In this scenario, the retina cannot collapse if its anterior
aspect is held fixed by the vitreous, so intra-retinal dehiscences occur in consequence to the
negative pressure and MMmay arise. Thus, in a similar fashion to macular holes, cysts are not
exudative, but tractional, as expected for non-inflammatory conditions such as LHON and
DOA. In eyes with lamellar macular holes and macular pucker, persistent vitreo-papillary ad-
hesion alters the vectors of force at the macula inducing tractional MM [30–34]. We propose
that a similar mechanism occurs in the MON-associated cases of optic atrophy
described herein.
Reduction of the RNFL thickness also occurs in inflammatory optic neuritis and MM have
been reported in these conditions and, in fact, proposed as a specific indicator of disease and
severity [11–13, 35]. The present study, as well as other studies, show that MM are therefore
likely to be a non-specific byproduct of optic atrophy, which becomes manifest only in a sub-
group of predisposed patients [16, 18–20, 27, 28]. We do not believe that MM are a biomarker
specific of inflammatory diseases of the optic nerve and retina, and they should not be used as
a marker for disease severity.
Table 3. Comparison of optical coherence tomography parameters (different macular thickness layers) between LHON and DOA patients with and
without macular microcysts and healthy controls.
Macular Thickness Average
(mμ)
p value p value p value
LHON-MM LHON no-
MM
Healthy
Controls
LHON-MM vs
controls
LHON-MM vs LHON-no-
MM
LHON no-MM vs
controls
INL 131.8±7 127.6±8 122.3±9 <0.05 ns >0.05
ONL 105.0±2 81.0±6 78.4±7 <0.001 <0.001 >0.05
DOA-MM DOA no-MM Healthy
Controls
DOA-MM vs
controls
DOA-MM vs DOA no-MM DOA no-MM vs
controls
INL 134.6±7 129.3±9 122.3±9 <0.01 ns <0.05
ONL 97.3±8 74.7±8 78.4±7 <0.001 <0.001 ns
Data are mean (SD). MM = macular microcysts. INL = inner nuclear layer including outer plexiform layers. ONL = outer nuclear layer including inner and
outer photoreceptor segments.
doi:10.1371/journal.pone.0127906.t003
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The MM patients here reported were all in their third decade, pointing to a possible role of
young age in favoring the MM formation, as already suggested by Abegg et al [36]. We propose
that the relatively young age of these patients supports the hypothesis of vitreo-retinal adhe-
sion, as vitreous is known to be more firmly adherent in youth, especially at the macular level
[37]. This firm adhesion at the macula produces a vector opposite to that generated by macular
thinning. It is not surprising, therefore, that MM are primarily seen in young-adults with severe
optic atrophy, such as MS and NMO, as well as in LHON and DOA.
It has also been proposed that MM are caused by the effects of trans-synaptic retrograde de-
generation [15, 36]. However, the latter was demonstrated to cause atrophic thinning of the
INL [38]. In contrast, our study demonstrated a thickening of INL. A possible explanation
might be that INL trans-synaptic retrograde atrophy induces a structural retinal weakening,
which, in conjunction with the tractional force of the vitreous, leads to the observed thickening,
and occasionally to MM. Furthermore, Abegg et al. [36] reported a patient who exhibited a de-
crease of MM in the course of a longitudinal observation period that cannot be explained by
any reversal of trans-synaptic degeneration, but might be due to release of vitreo-macular ad-
hesion from age-related changes.
Another notable finding is the topographic localization of the MM in the macula of these
patients. Previous studies have shown that the posterior vitreous cortex overlying the macula is
thinned in a disc-shaped area centered at the fovea that is about 4 disc diameters in size [39–
41]. It is thought that the arcuate edge of this disc-shaped zone represents a site of increased
vitreo-retinal adhesion and a source of abnormal vitreo-macular traction. This zone appears to
correspond quite closely with the distribution of MM in the patients described here, further
supporting the hypothesis of vitreo-macular adhesion/traction as a factor underlying the
pathophysiology of MM.
All considered, the hypothesis of vitreous traction as major force generating MM, is a likely
explanation, which does not exclude the co-participation of other factors including trans-syn-
aptic retrograde degeneration or other unknown mechanisms that may all act synergistically in
a small subset of patients. Future studies are warranted, in particular including a larger sample
size of patients with MM. This would allow to avoid the potential limitation of the within-sub-
ject inter-eye correlation due to inclusion of both eyes as in the current study. Moreover, it
would be useful to use ultrasonography for evaluation of posterior vitreous detachment, as well
as OCT imaging of the vitreo-papillary interface to carefully assess the role of vitreous in the
pathogenesis of MM in these and other optic nerve disorders.
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